US Patent Issued to Myoforte Therapeutics on Feb. 24 for "PGDH inhibitors and methods of making and using" (California Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,493, issued on Feb. 24, was assigned to Myoforte Therapeutics Inc. (Menlo Park, Calif.).

"PGDH inhibitors and methods of making and using" was invented by Roopa Rai (San Carlos, Calif.), Robert Booth (Los Altos Hills, Calif.) and Michael J. Green (Half Moon Bay, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin level."

The patent was filed on Dec. 6, 2023, under Application No. 18/531,523.

*For further information, including images, charts and tables, please visi...